Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Apexigen Inc. Warrant (NASDAQ : APGNW) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Apexigen Inc is a clinical-stage biopharmaceutical company focusing on the discovery and development of innovative antibody-based therapeutics for the treatment of cancer with a focus on immuno-oncology. The company's pipeline of immuno-oncology therapeutic candidates is led by sotigalimab, which is in clinical development, and also includes several preclinical stage immune-oncology programs.
Quote
| Last: | $ |
|---|---|
| Change Percent: | |
| Open: | $ |
| Close: | $ |
| High: | $ |
| Low: | $ |
| Volume: | 0 |
| Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Stock Data
| Market Cap: | $0 |
|---|---|
| Float: | N/A |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | |
| Sector: | |
| Country: | |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Apexigen Inc. Warrant (NASDAQ: APGNW).
